|
Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer |
|
|
|
Titel: |
Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer |
Auteur: |
Nishio, Makoto Horiike, Atsushi Murakami, Haruyasu Yamamoto, Nobuyuki Kaneda, Hiroyasu Nakagawa, Kazuhiko Horinouchi, Hidehito Nagashima, Masaki Sekiguchi, Masaru Tamura, Tomohide |
Verschenen in: |
Lung cancer |
Paginering: |
Jaargang 88 (2015) nr. 3 pagina's 7 p. |
Jaar: |
2015 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|